Klepsydra Edge AI Integration Partner Program
Are you a systems integrator, OEM, or solution provider seeking to embed advanced edge AI capabilities into your products? The Klepsydra Edge AI Integration Partner Program is designed to help you integrate Klepsydra’s patented edge AI software, enabling high-performance, scalable intelligence across diverse hardware platforms—from low-cost processors to AI accelerators.

Partnership Program :
Target Partner Location :
Worldwide
Target Partner Persona :
Aerospace integrators, robotics system providers, automotive OEMs, industrial automation firms, and IoT edge device manufacturers eager to enhance products with efficient onboard AI
🌟 Key Benefits of the Program:
- Carrier-Grade Edge Intelligence: Deploy Klepsydra’s proven edge AI software solutions—even tested in space—to enhance reliability and performance.
- Hardware Agnostic Integration: Support across a range of processors and accelerators, ensuring flexibility in deployment across devices and industries.
- Performance & Efficiency Balance: Optimized for real-time inferencing with minimal resource consumption, ideal for constrained environments.
- Collaborative R&D Support: Partner with Klepsydra’s team to co-develop and refine edge-AI use cases tailored to customer needs.
- Accelerate Time-to-Market: Leverage ready-made AI stacks and pre-validated modules, cutting development cycles significantly.
✅ Eligibility Criteria:
- Must be a systems integrator, device manufacturer, OEM, or platform provider working with edge computing, robotics, aerospace, or automotive domains.
- Capability to integrate third-party software into existing hardware or devices.
- Committed to beta testing, joint development, or proof-of-concept implementations.
- Aligned with agile development principles and co-innovation processes.
Rich Text

Frequently asked questions
There is no FAQs yet.
End User
PerioTrap Pharmaceuticals GmbH
Size :
11-50
Location :
Germany
Industry:
Pharmaceuticals

Person's name
Title of the person
Other Collab Calls

Investment & Funding Partner
Venture capital firms, corporate investors, family offices, and strategic healthcare investors seeking early participation in high-impact biotech ventures
